Medical Net, Inc. (TYO:3645)
Japan · Delayed Price · Currency is JPY 257.00
+9.00 (3.63%)
Sep 1, 2026, 3:30 PM JST
Medical Net Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Income | 259 | 25 | 153 | 250 | 538 |
Depreciation & Amortization | 77 | 76 | 53 | 61 | 29 |
Loss (Gain) From Sale of Assets | 8 | 154 | 165 | 141 | - |
Loss (Gain) From Sale of Investments | - | -352 | 4 | 40 | - |
Other Operating Activities | -67 | -122 | -159 | -158 | -159 |
Change in Accounts Receivable | -83 | -62 | -115 | -30 | -44 |
Change in Inventory | -38 | -95 | -72 | 5 | -28 |
Change in Accounts Payable | -37 | -98 | 45 | 62 | 24 |
Change in Other Net Operating Assets | -21 | 394 | 45 | 58 | -18 |
Operating Cash Flow | 98 | -80 | 119 | 429 | 342 |
Operating Cash Flow Growth | - | - | -72.26% | 25.44% | -12.53% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Capital Expenditures | -8 | -131 | -32 | -19 | -2 |
Sale of Property, Plant & Equipment | 2 | - | 5 | 4 | - |
Cash Acquisitions | - | -33 | -224 | - | -340 |
Divestitures | - | -52 | - | - | - |
Investment in Securities | 22 | - | - | -27 | -3 |
Other Investing Activities | 68 | -36 | -37 | -23 | -13 |
Investing Cash Flow | 87 | -259 | -285 | -62 | -355 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Short-Term Debt Issued | 236 | 299 | - | 50 | 390 |
Long-Term Debt Issued | - | 130 | 360 | - | - |
Total Debt Issued | 236 | 429 | 360 | 50 | 390 |
Short-Term Debt Repaid | - | - | -150 | - | - |
Long-Term Debt Repaid | -69 | -79 | -37 | -33 | -74 |
Total Debt Repaid | -69 | -79 | -187 | -33 | -74 |
Net Debt Issued (Repaid) | 167 | 350 | 173 | 17 | 316 |
Repurchase of Common Stock | 155 | -99 | - | - | - |
Common Dividends Paid | -26 | -26 | -22 | -35 | -34 |
Other Financing Activities | -6 | -6 | -7 | 1 | - |
Financing Cash Flow | 290 | 219 | 144 | -17 | 282 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Foreign Exchange Rate Adjustments | 39 | 17 | 16 | 35 | -9 |
Miscellaneous Cash Flow Adjustments | 2 | -1 | 1 | -1 | - |
Net Cash Flow | 516 | -104 | -5 | 384 | 260 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | 90 | -211 | 87 | 410 | 340 |
Free Cash Flow Growth | - | - | -78.78% | 20.59% | -10.05% |
Free Cash Flow Margin | 1.34% | -3.47% | 1.66% | 9.11% | 9.08% |
Free Cash Flow Per Share | 9.79 | -23.64 | 9.62 | 45.76 | 38.85 |
Levered Free Cash Flow | 56.63 | -160 | 89.13 | 372 | 174.63 |
Unlevered Free Cash Flow | 66 | -153.13 | 92.88 | 373.88 | 175.25 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash Interest Paid | 15 | 11 | 6 | 3 | 1 |
Cash Income Tax Paid | 66 | 123 | 158 | 159 | 160 |
Change in Working Capital | -179 | 139 | -97 | 95 | -66 |